These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19067304)

  • 1. [A psychosis proneness-persistence-impairment model of psychotic disorders].
    van Os J; Verkooyen R; Hendriks M; Henquet C; Bak M; Marcelis M; Delespaul P; Krabbendam L; Myin-Germeys I
    Tijdschr Psychiatr; 2008; 50 Spec no.():77-83. PubMed ID: 19067304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model.
    Cougnard A; Marcelis M; Myin-Germeys I; De Graaf R; Vollebergh W; Krabbendam L; Lieb R; Wittchen HU; Henquet C; Spauwen J; Van Os J
    Psychol Med; 2007 Apr; 37(4):513-27. PubMed ID: 17288646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.
    van Os J; Linscott RJ; Myin-Germeys I; Delespaul P; Krabbendam L
    Psychol Med; 2009 Feb; 39(2):179-95. PubMed ID: 18606047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment.
    Spauwen J; Krabbendam L; Lieb R; Wittchen HU; van Os J
    Psychol Med; 2006 Mar; 36(3):407-15. PubMed ID: 16403242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychosis proneness: psychosis persistence model as an explanation for the association between urbanicity and psychosis.
    Spauwen J; Van Os J
    Epidemiol Psichiatr Soc; 2006; 15(4):252-7. PubMed ID: 17203616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stress and psychosis: is sensitisation the underlying mechanism?].
    Collip D; Myin-Germeys I; Van Winkel R; van Os J
    Tijdschr Psychiatr; 2009; 51(8):559-67. PubMed ID: 19658068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the wider social environment moderates the association between familial liability and psychosis spectrum outcome.
    Binbay T; Drukker M; Alptekin K; Elbi H; Aksu Tanık F; Özkınay F; Onay H; Zağlı N; van Os J
    Psychol Med; 2012 Dec; 42(12):2499-510. PubMed ID: 22717152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Environmental and psychosocial aspects of genetic research in psychiatry].
    Van Os J; Verdoux H
    Encephale; 1998; 24(2):125-31. PubMed ID: 9622791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of Usher's syndrome associated with psychotic symptoms: diagnosis and follow-up in a psychiatric unit].
    Viala A; Nicot T; Levy F; Vacheron MN
    Encephale; 2009 Jun; 35(3):286-91. PubMed ID: 19540416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental course of subclinical positive and negative psychotic symptoms and their associations with genetic risk status and impairment.
    Janssens M; Boyette LL; Heering HD; Bartels-Velthuis AA; Lataster T;
    Schizophr Res; 2016 Jul; 174(1-3):177-182. PubMed ID: 27157801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis.
    Myin-Germeys I; van Os J
    Clin Psychol Rev; 2007 May; 27(4):409-24. PubMed ID: 17222489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 13. Postpartum psychosis: detection of risk and management.
    Spinelli MG
    Am J Psychiatry; 2009 Apr; 166(4):405-8. PubMed ID: 19339365
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction. Antipsychotic agents: clinical, economic, and legal considerations in the treatment of psychosis.
    Lehman AF
    J Clin Psychiatry; 1999; 60 Suppl 19():3-4. PubMed ID: 10507274
    [No Abstract]   [Full Text] [Related]  

  • 15. Translational research approach to biological and modifiable risk factors of psychosis and affective disorders.
    Baune BT; Thome J
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():28-34. PubMed ID: 21905992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper.
    Garety PA; Bebbington P; Fowler D; Freeman D; Kuipers E
    Psychol Med; 2007 Oct; 37(10):1377-91. PubMed ID: 17335638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk.
    Myin-Germeys I; Marcelis M; Krabbendam L; Delespaul P; van Os J
    Biol Psychiatry; 2005 Jul; 58(2):105-10. PubMed ID: 16038680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
    Buckley PF
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.